Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4279404018 | Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4279405017 | Product containing only atoltivimab and maftivimab and odesivimab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | Plays role | Antiviral therapeutic role | true | Inferred relationship | Some | ||
| Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | est un(e) (attribut) | Product containing only atoltivimab and maftivimab and odesivimab (medicinal product) | true | Inferred relationship | Some | ||
| Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | est un(e) (attribut) | Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
| Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | a pour principe actif (attribut) | Atoltivimab (substance) | true | Inferred relationship | Some | 1 | |
| Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | a pour principe actif (attribut) | Maftivimab | true | Inferred relationship | Some | 2 | |
| Atoltivimab and maftivimab and odesivimab only product in parenteral dose form | a pour principe actif (attribut) | Odesivimab (substance) | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR